Vinod Rustgi, MD
Enriched profileDistinguished Professor of Medicine; Clinical Director of Hepatology; Director, Center for Liver Diseases; Associate Program Director, Gastroenterology/Hepatology Fellowship · Rutgers Robert Wood Johnson Medical School
Vinod Rustgi is Distinguished Professor of Medicine; Clinical Director of Hepatology; Director, Center for Liver Diseases; Associate Program Director, Gastroenterology/Hepatology Fellowship at Rutgers Robert Wood Johnson Medical School. OpenAlex indexes 296 publications with 19,794 citations (h-index 44); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Gastroenterology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Vinod K. Rustgi, MD, is Distinguished Professor of Medicine at Rutgers Robert Wood Johnson Medical School, Division of Gastroenterology and Hepatology, Department of Medicine, New Brunswick, NJ. The public record shows 296 publications with 19,794 citations (h-index 44), centered on Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Liver Disease and Transplantation. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 19 companies.
- Most recent indexed publication: 2024 · Alimentary pharmacology & therapeutics
- Top research focus: Liver Disease Diagnosis and Treatment
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 19 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 129.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
Sponsor: Romark Laboratories L.C.
- HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection
Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Industry payments
Updated 27 Aug 2026
19 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year202585 payments$109,441openpaymentsdata.cms.gov ↗
- Gilead Sciences, Inc.Program year202523 payments$13,362openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202510 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
60.8%Proton pump inhibitor24.5%Omeprazole57%Pantoprazole Sodium43%Part D<11 patientsBile Acid24.5%Ursodiol100%Part D<11 patientsCancer & immunology
21%Calcineurin inhibitor11.9%Tacrolimus100%Part D<11 patientsPurine Antimetabolite9.1%Azathioprine100%Part D<11 patientsCardiovascular
18.2%Calcium channel blocker9.1%Amlodipine Besylate100%Part D<11 patientsAldosterone antagonist (MRA)9.1%Spironolactone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes.
Alimentary pharmacology & therapeutics
Article2024 - Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment.
Journal of clinical and translational hepatology
Review2023 - Wilson's Disease: An Analysis of Health Care Use and Cost Burden of Commercially Insured Adults in the United States.
Hepatology communications
Article2022 - Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease.
Journal of medical economics
Article2022 - Genetic mutation and biological pathway prediction based on whole slide images in breast carcinoma using deep learning.
NPJ precision oncology
Article2021
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/vinod-rustgi-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Vinod-Rustgi-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/vinod-rustgi-69b882a
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- X / Twitter
x.com/AGA_Gastro/status/1400145576625414148
- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthcare6.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rwjms.rutgers.edu ↗
- Board certified
Gastroenterology and Internal Medicine (fellowship training in gastroenterology/liver diseases at Stanford and NIH)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- Governing Board Member
American Association for the Study of Liver Diseases (AASLD)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rwjms.rutgers.edu ↗ - Formerly Medical Director of Liver Transplantation
Thomas E. Starzl Transplantation Institute, University of Pittsburgh
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rwjms.rutgers.edu ↗
Awards & honors
honors on the public record- Fellow
American Association for the Study of Liver Diseases (AASLD)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rwjms.rutgers.edu ↗ - Fellow
Royal College of Physicians
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Secondary affiliations
appointments beyond the home institution- Professor of Epidemiology
Rutgers School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rwjms.rutgers.edu ↗ - Professor
Department of Pathology and Laboratory Medicine, Rutgers RWJMS
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rwjms.rutgers.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona